S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NYSE:ELV

Elevance Health - ELV Stock Forecast, Price & News

$491.77
+0.92 (+0.19%)
(As of 08/18/2022 05:16 PM ET)
Add
Compare
Today's Range
$487.82
$493.20
50-Day Range
$444.32
$498.30
52-Week Range
$355.43
$533.68
Volume
407,719 shs
Average Volume
1.13 million shs
Market Capitalization
$118.03 billion
P/E Ratio
19.72
Dividend Yield
1.04%
Price Target
$558.30

Elevance Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.84 Rating Score
Upside/​Downside
13.6% Upside
$558.30 Price Target
Short Interest
Healthy
0.91% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.55mentions of Elevance Health in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$3.76 M Sold Last Quarter
Proj. Earnings Growth
12.53%
From $28.82 to $32.43 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.27 out of 5 stars

Medical Sector

4th out of 1,119 stocks

Hospital & Medical Service Plans Industry

1st out of 11 stocks

ELV stock logo

About Elevance Health (NYSE:ELV) Stock

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ELV shares. Wells Fargo & Company decreased their price objective on shares of Elevance Health from $586.00 to $580.00 and set an "overweight" rating for the company in a report on Wednesday, May 25th. Royal Bank of Canada dropped their price objective on Elevance Health from $544.00 to $505.00 in a research note on Thursday, July 21st. StockNews.com assumed coverage on Elevance Health in a report on Thursday, July 7th. They set a "strong-buy" rating on the stock. Stephens reduced their target price on shares of Elevance Health to $550.00 in a research note on Friday, July 22nd. Finally, BMO Capital Markets upped their target price on Elevance Health from $540.00 to $625.00 and gave the company an "outperform" rating in a research note on Monday, April 25th. Three investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Elevance Health presently has an average rating of "Moderate Buy" and an average target price of $558.30.

Elevance Health Trading Down 0.3 %

Shares of Elevance Health stock opened at $490.85 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.36 and a debt-to-equity ratio of 0.59. The company has a fifty day simple moving average of $475.54 and a 200-day simple moving average of $480.57. The stock has a market cap of $117.80 billion, a price-to-earnings ratio of 19.68, a PEG ratio of 1.42 and a beta of 0.90. Elevance Health has a 12-month low of $355.43 and a 12-month high of $533.68.

Elevance Health (NYSE:ELV - Get Rating) last announced its quarterly earnings results on Wednesday, July 20th. The company reported $8.04 earnings per share for the quarter, beating analysts' consensus estimates of $7.74 by $0.30. Elevance Health had a net margin of 4.09% and a return on equity of 19.20%. The firm had revenue of $38.48 billion during the quarter, compared to analysts' expectations of $38.05 billion. During the same period in the previous year, the company earned $7.03 earnings per share. Elevance Health's quarterly revenue was up 15.6% compared to the same quarter last year. On average, equities analysts forecast that Elevance Health will post 28.81 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 23rd. Stockholders of record on Friday, September 9th will be issued a $1.28 dividend. This represents a $5.12 annualized dividend and a dividend yield of 1.04%. The ex-dividend date is Thursday, September 8th. Elevance Health's payout ratio is currently 20.53%.

Insider Activity

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 6,328 shares of the firm's stock in a transaction on Thursday, June 9th. The shares were sold at an average price of $488.60, for a total transaction of $3,091,860.80. Following the transaction, the executive vice president now directly owns 14,529 shares of the company's stock, valued at approximately $7,098,869.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Robert L. Dixon, Jr. sold 420 shares of Elevance Health stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $497.14, for a total value of $208,798.80. Following the sale, the director now owns 9,491 shares of the company's stock, valued at $4,718,355.74. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Charles Morgan Kendrick, Jr. sold 6,328 shares of the stock in a transaction dated Thursday, June 9th. The stock was sold at an average price of $488.60, for a total transaction of $3,091,860.80. Following the transaction, the executive vice president now directly owns 14,529 shares of the company's stock, valued at $7,098,869.40. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company's stock.

Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Stock News Headlines

Elevance Health: Continues To Grow, A Strong Buy
Elevance Health Inc
Elevance Health Inc. (NYSE: ELV)
Elevance Health Inc.: Reaffirming BUY and $560 target
Elevance Health (NYSE:ELV) PT Lowered to $550.00 at Stephens
See More Headlines
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Company Calendar

Ex-Dividend for 6/24 Dividend
6/09/2022
Dividend Payable
6/24/2022
Last Earnings
7/20/2022
Today
8/18/2022
Ex-Dividend for 9/23 Dividend
9/08/2022
Dividend Payable
9/23/2022
Next Earnings (Estimated)
10/18/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
Sector
Medical
CUSIP
94973V10
Employees
98,200
Year Founded
2004

Price Target and Rating

Average Stock Price Forecast
$558.30
High Stock Price Forecast
$642.00
Low Stock Price Forecast
$485.00
Forecasted Upside/Downside
+13.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.84
Research Coverage
19 Analysts

Profitability

Net Income
$6.10 billion
Pretax Margin
5.27%

Debt

Sales & Book Value

Annual Sales
$138.64 billion
Cash Flow
$31.75 per share
Book Value
$149.45 per share

Miscellaneous

Free Float
239,353,000
Market Cap
$118.03 billion
Optionable
Optionable
Beta
0.90

Social Links


Key Executives

  • Ms. Gail Koziara Boudreaux (Age 61)
    Pres, CEO & Director
    Comp: $6.15M
  • Mr. John Edward Gallina (Age 62)
    Exec. VP & CFO
    Comp: $2.39M
  • Ms. Gloria Marie McCarthyMs. Gloria Marie McCarthy (Age 69)
    Exec. VP & Chief Admin. Officer
    Comp: $2.27M
  • Mr. Peter David Haytaian Esq. (Age 52)
    Exec. VP and Pres of Diversified Bus. Group & IngenioRx
    Comp: $2.39M
  • Ms. Felicia Farr Norwood (Age 62)
    Exec. VP & Pres of Gov. Bus. Division
    Comp: $2.33M
  • Mr. Scott Wayne Anglin
    SVP, Treasurer & Chief Investment Officer
  • Mr. Ronald William Penczek (Age 57)
    Sr. VP, Controller & Chief Accounting Officer
  • Mr. Anil Bhatt
    Chief Technology Officer
  • Mr. Stephen Vartan Tanal C.F.A.
    VP of Investor Relations
  • Mr. Blair Williams Todt (Age 54)
    EVP, Chief Legal Officer and Interim Head of HR, Global Security & Safety Team













ELV Stock - Frequently Asked Questions

Should I buy or sell Elevance Health stock right now?

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elevance Health in the last year. There are currently 3 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ELV shares.
View ELV analyst ratings
or view top-rated stocks.

What is Elevance Health's stock price forecast for 2022?

19 brokers have issued 12-month price objectives for Elevance Health's shares. Their ELV share price forecasts range from $485.00 to $642.00. On average, they expect the company's stock price to reach $558.30 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price.
View analysts price targets for ELV
or view top-rated stocks among Wall Street analysts.

How have ELV shares performed in 2022?

Elevance Health's stock was trading at $463.54 at the beginning of the year. Since then, ELV stock has increased by 5.9% and is now trading at $490.85.
View the best growth stocks for 2022 here
.

When is Elevance Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 18th 2022.
View our ELV earnings forecast
.

How were Elevance Health's earnings last quarter?

Elevance Health Inc. (NYSE:ELV) announced its earnings results on Wednesday, July, 20th. The company reported $8.04 earnings per share for the quarter, beating the consensus estimate of $7.74 by $0.30. The company earned $38.48 billion during the quarter, compared to analyst estimates of $38.05 billion. Elevance Health had a net margin of 4.09% and a trailing twelve-month return on equity of 19.20%. Elevance Health's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same quarter last year, the company posted $7.03 EPS.

How often does Elevance Health pay dividends? What is the dividend yield for Elevance Health?

Elevance Health announced a quarterly dividend on Thursday, July 21st. Investors of record on Friday, September 9th will be given a dividend of $1.28 per share on Friday, September 23rd. This represents a $5.12 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Thursday, September 8th.
Read our dividend analysis for ELV
.

Is Elevance Health a good dividend stock?

Elevance Health (NYSE:ELV) pays an annual dividend of $5.12 per share and currently has a dividend yield of 1.04%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 20.53%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ELV will have a dividend payout ratio of 15.79% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ELV.

What guidance has Elevance Health issued on next quarter's earnings?

Elevance Health updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share (EPS) guidance of $28.70- for the period, compared to the consensus estimate of $28.64. The company issued revenue guidance of -.

What is Elevance Health's stock symbol?

Elevance Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELV."

How do I buy shares of Elevance Health?

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elevance Health's stock price today?

One share of ELV stock can currently be purchased for approximately $490.85.

How much money does Elevance Health make?

Elevance Health (NYSE:ELV) has a market capitalization of $117.80 billion and generates $138.64 billion in revenue each year. The company earns $6.10 billion in net income (profit) each year or $24.94 on an earnings per share basis.

How many employees does Elevance Health have?

The company employs 98,200 workers across the globe.

Does Elevance Health have any subsidiaries?
The following companies are subsidiares of Elevance Health: 1-800 Contacts, AIM Specialty Health, AMERIGROUP Community Care of New Mexico Inc., AMERIGROUP Corporation, AMERIGROUP Maryland Inc., AMERIGROUP New Jersey Inc., AMERIGROUP Ohio Inc., AMERIGROUP Tennessee Inc., AMERIGROUP Texas Inc., AMERIGROUP Washington Inc., AMGP Georgia Managed Care Company Inc., ATH Holding Company LLC, America's 1st Choice of South Carolina Inc., America's Health Management Services Inc., American Imaging Management Inc., America’s 1st Choice, Amerigroup, Amerigroup Delaware Inc., Amerigroup District of Columbia Inc., Amerigroup Health Plan of Louisiana Inc., Amerigroup IPA of New York LLC, Amerigroup Insurance Company, Amerigroup Iowa Inc., Amerigroup Kansas Inc., Amerigroup Mississippi Inc., Amerigroup Oklahoma Inc., Amerigroup Partnership Plan LLC, Amerigroup Pennsylvania Inc., Anthem Blue Cross Life and Health Insurance Company, Anthem Financial Inc., Anthem Health Plans Inc., Anthem Health Plans of Kentucky Inc., Anthem Health Plans of Maine Inc., Anthem Health Plans of New Hampshire Inc., Anthem Health Plans of Virginia Inc., Anthem Holding Corp., Anthem Innovation Israel Ltd., Anthem Insurance Companies Inc., Anthem Kentucky Managed Care Plan Inc., Anthem Life & Disability Insurance Company, Anthem Life Insurance Company, Anthem Partnership Holding Company LLC, Anthem Services Company LLC, Anthem Southeast Inc., Anthem UM Services Inc., Anthem Workers' Compensation LLC, Applied Pathways LLC, Arcus Enterprises Inc., Aspire Health Inc., Aspire Healthcare Corp, Associated Group Inc., Beacon Health Options, Blue Cross Blue Shield Healthcare Plan of Georgia Inc., Blue Cross Blue Shield of Wisconsin, Blue Cross of California, Blue Cross of California Partnership Plan Inc., CareMarket Inc., CareMore Health Plan, CareMore Health Plan of Arizona Inc., CareMore Health Plan of Nevada, CareMore Health Plan of Texas Inc., CareMore Health System, CareMore LLC, Cerulean Companies Inc., Claim Management Services Inc., Community Care Health Plan of Louisiana Inc., Community Care Health Plan of Nevada Inc., Community Insurance Company, Compcare Health Services Insurance Corporation, Crossroads Acquisition Corp., DBG Holdings Inc., DeCare Analytics LLC, DeCare Dental Health International LLC, DeCare Dental Insurance Ireland Ltd., DeCare Dental LLC, DeCare Dental Networks LLC, DeCare Operations Ireland Limited, Delivery Network LLC, Designated Agent Company Inc., EHC Benefits Agency Inc., EasyScripts Cutler Bay LLC, EasyScripts Hialeah LLC, EasyScripts LLC, EasyScripts Westchester LLC, Empire HealthChoice Assurance Inc., Empire HealthChoice HMO Inc., Federal Government Solutions LLC, Freedom Health Inc., Global TPA LLC, Golden West Health Plan Inc., Greater Georgia Life Insurance Company, HEP AP Holdings Inc., HMO Colorado Inc., HMO Missouri Inc., Health Core Inc., Health Management Corporation, Health Ventures Partner L.L.C., HealthKeepers Inc., HealthLink HMO Inc., HealthLink Inc., HealthLink Insurance Company, HealthPlus HP LLC, HealthSun Health Plans, HealthSun Health Plans Inc., HealthSun Holdings LLC, HealthSun Management LLC, HealthSun Physicians Network I LLC, HealthSun Physicians Network LLC, Healthy Alliance Life Insurance Company, Highland Acquisition Holdings LLC, Highland Holdco Inc., Highland Intermediate Holdings LLC, Highland Investor Holdings LLC, Imaging Management Holdings LLC, IngenioRx Inc., Legato Health Technologies LLP, Legato Health Technologies Philippines Inc., Legato Holdings I Inc., Legato Holdings II LLC, Living Complete Technologies Inc., Matthew Thornton Health Plan Inc., Memphis Supportive Care Partnership LLC, Meridian Resource Company LLC, Missouri Care Incorporated, NGS Federal LLC, Nash Holding Company LLC, National Government Services Inc., New England Research Institutes Inc., Optimum Healthcare Inc., Park Square Holdings Inc., Park Square I Inc., Park Square II Inc., Pasteur Medical Bird Road LLC, Pasteur Medical Center LLC, Pasteur Medical Cutler Bay LLC, Pasteur Medical Group LLC, Pasteur Medical Hialeah Gardens LLC, Pasteur Medical Holdings LLC, Pasteur Medical Kendall LLC, Pasteur Medical Management LLC, Pasteur Medical Miami Gardens LLC, Pasteur Medical North Miami Beach LLC, Pasteur Medical Partners LLC, Resolution Health Inc, Resolution Health Inc., RightCHOICE Managed Care Inc., Rocky Mountain Hospital and Medical Service Inc., SellCore Inc., Simply Healthcare Holdings, Simply Healthcare Plans Inc., Southeast Services Inc., State Sponsored DM Services Inc., The Anthem Companies Inc., The Anthem Companies of California Inc., TrustSolutions LLC, UNICARE Health Plan of West Virginia Inc., UNICARE Illinois Services Inc., UNICARE National Services Inc., UniCare Life & Health Insurance Company, UniCare Specialty Services Inc., Valus Inc., WPMI LLC, WellCare of Nebraska Inc., WellPoint Acquisition LLC, WellPoint California Services Inc., WellPoint Dental Services Inc., WellPoint Health Solutions Inc., WellPoint Holding Corp., WellPoint Information Technology Services Inc., WellPoint Insurance Services Inc., WellPoint Military Care Corporation, Wellmax Health Medical Centers LLC, Wellmax Health Physicians Network LLC, and Wisconsin Collaborative Insurance Company.
Read More
When was Elevance Health founded?

Elevance Health was founded in 2004.

How can I contact Elevance Health?

Elevance Health's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The official website for the company is www.antheminc.com. The company can be reached via phone at (800) 331-1476, via email at chris.rigg@anthem.com, or via fax at 317-488-6275.

This page (NYSE:ELV) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.